Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2901–2950 of 34667
Renger van den Heuvel was appointed as the Chief Executive Officer of the Company and as a member of the Company’s Board of Directors.
On April 14, 2025, the Company’s Board of Directors, pursuant to a Board resolution, established the size of the Board at 9 directors, and elected Meghan Pasricha, age 39, to serve as a Class III director until the 2025 Annual Meeting of Stockholders.
On April 15, 2025, Rhinebeck Bancorp, Inc. (the “Company”), its wholly-owned subsidiary, Rhinebeck Bank (the “Bank”), and its mutual holding company, Rhinebeck Bancorp, MHC (the “MHC”), announced that Sharon McGinnis and Nancy K. Patzwahl have been appointed to the Board of Directors of the Company, the Bank and the MHC, effective April 15, 2025.
On April 15, 2025, Rhinebeck Bancorp, Inc. (the “Company”), its wholly-owned subsidiary, Rhinebeck Bank (the “Bank”), and its mutual holding company, Rhinebeck Bancorp, MHC (the “MHC”), announced that Sharon McGinnis and Nancy K. Patzwahl have been appointed to the Board of Directors of the Company, the Bank and the MHC, effective April 15, 2025.
On April 8, 2025, Christopher Wright notified Roper Technologies, Inc. (the “Company”) of his intention to retire from the Company’s Board of Directors, effective as of the Company’s 2025 Annual Meeting of Shareholders to be held on June 10, 2025.
David H. Y. Ho, a member of the Board, notified the Company of his decision to resign from the Board.
the Board increased the size of the Board to 9 members and appointed Richard L. Clemmer and Chris Koopmans to the Board, effective immediately.
the Board increased the size of the Board to 9 members and appointed Richard L. Clemmer and Chris Koopmans to the Board, effective immediately.
John Freund, M.D., a member of the Board of Directors (the “Board”) of Sutro Biopharma, Inc., a Delaware corporation (the “Company”) since 2014, informed the Board of his decision to not stand for re-election to the Board.
On April 11, 2024, Blackstone Infrastructure Strategies Associates L.P., the general partner (the “General Partner”) of Blackstone Infrastructure Strategies L.P. (the “Fund”), and the Fund’s board of directors (the “Board”) appointed Susan Roth Katzke to the Board as an independent director.
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
Mr. Anquan Wang, Mr. Haichen Wang and Mr. Benjamin Worthy James will serve as directors of Merger Sub II, the Surviving Company.
Mr. Anquan Wang, Mr. Haichen Wang and Mr. Benjamin Worthy James will serve as directors of Merger Sub II, the Surviving Company.
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
Mr. Anquan Wang, Mr. Haichen Wang and Mr. Benjamin Worthy James will serve as directors of Merger Sub II, the Surviving Company.
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
On April 11, 2025, the Board of Directors (the “Board”) of Butler National Corporation (the “Company”) was increased in size from 6 director positions to 7 and Julie M. Bowen was appointed to fill the newly created vacancy.
On April 8, 2025, HA Sustainable Infrastructure Capital, Inc. (the “Company”) announced the election of Barry E. Welch and Laura A. Schulte to become a new independent directors of the Company’s Board of Directors (the “Board”) effective April 15, 2025.
On April 8, 2025, HA Sustainable Infrastructure Capital, Inc. (the “Company”) announced the election of Barry E. Welch and Laura A. Schulte to become a new independent directors of the Company’s Board of Directors (the “Board”) effective April 15, 2025.
On April 10, 2025, Bruce Downey notified the Board of Directors (the “ Board ”) of C4 Therapeutics, Inc. (the “ Company ”) of his intention to retire from the Board and not to stand for reelection at the 2025 Annual Meeting of Stockholders.
On April 12, 2025, Stuart Diamond, a member of the board of directors (the “Board”) of bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), notified the Company of his decision not to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On April 10, 2025, the Board appointed Guoquan (Paul) Huang to serve on the board of directors, effective upon the closing of the Private Placement and the satisfactory completion of a background check, as a Class II director for a term expiring at the 2026 annual meeting of stockholders and until his successor is elected and qualified or until his earlier death, resignation or removal or as otherwise provided in the bylaws of the Company.
On April 11, 2025, the Board approved the appointment of Karen Dykstra as a director of the Company, effective as of April 14, 2025.
On April 9, 2025, Enrique Salem notified Atlassian Corporation (the “ Company ”) of his decision to retire as a director of the Company, effective as of April 14, 2025.
On April 8, 2025, Nixxy, Inc. (the “Company”) appointed Ashissh Raichura as a member of the Company’s Board of Directors (the “Board”).
On April 4, 2025, Gary Kiss resigned from his position as director of BioRegenx, Inc., effective immediately.
On April 7, 2025, Gary Hennerberg resigned from his position as director of BioRegenx, Inc., effective immediately.
On April 14, 2025, Bruce Greenstein notified Viemed Healthcare, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors, effective immediately.
On April 2, 2025, Gerald W. Shields, former Chief Executive Officer and the only non-independent director of the Board of Directors ("Board") of Citizens, Inc. (the “Company”), submitted a written resignation from the Board contingent upon the Board accepting such resignation and selecting an effective date.
all of the members of the Company’s Board of Directors immediately prior to the Effective Time resigned as directors of the Company.
Joseph C. Hete was reappointed as a director of the Board of Directors of the surviving company.
On April 10, 2025, Steven J. Moskowitz, former President and Chief Executive Officer of Crown Castle Inc. (“Company”), effectuated his resignation from the Board of Directors of the Company, effective immediately.
the effectiveness of Ms. Wellman’s resignation.
Effective as of the Closing, the following people were appointed as directors of the Company: • Andrew Milgram; • Sarah E. Feinberg; • Harvey Golub; and • Frederick C. Herbst.
Effective as of the Closing, the following people were appointed as directors of the Company: • Andrew Milgram; • Sarah E. Feinberg; • Harvey Golub; and • Frederick C. Herbst.
Effective as of the Closing, the following people were appointed as directors of the Company: • Andrew Milgram; • Sarah E. Feinberg; • Harvey Golub; and • Frederick C. Herbst.
Effective as of the Closing, the following people were appointed as directors of the Company: • Andrew Milgram; • Sarah E. Feinberg; • Harvey Golub; and • Frederick C. Herbst.
On April 9, 2025, Sandra Bell, an independent member of the board of directors (the “Board”) of Chimera Investment Corporation (the “Company”), notified the Company that she intends to resign from the Board, effective immediately.
Mr. Shibu Kizhakevilayil resigned as a director of the Company, effective immediately.
the Board appointed Ms. Sujatha Ramesh as an executive director of the Company, along with their current role as the Chief Operating Officer of the Company.
On April 4, 2025, Olga Smirnova stepped down as a member of the board of directors of US Lighting Group, Inc. (“ USLG ” or the “ company ”) due to personal circumstances.
elected Dina Powell McCormick and Patrick Collison as members of the Board, effective April 15, 2025.
elected Dina Powell McCormick and Patrick Collison as members of the Board, effective April 15, 2025.
the Board had appointed Anton Levy to the Board effective immediately following the 2025 Annual Meeting of Stockholders
Dr. John Malone notified the Board of Directors (the “Board”) of Warner Bros. Discovery, Inc. (the “Company”) of his decision to not stand for re-election following the expiration of his current term
On April 10, 2025, Adam Chambers, Angel Liriano, David Piedra and Joseph Tung were appointed to the Board of Directors of the Company.
On April 10, 2025, Adam Chambers, Angel Liriano, David Piedra and Joseph Tung were appointed to the Board of Directors of the Company.
On April 10, 2025, Adam Chambers, Angel Liriano, David Piedra and Joseph Tung were appointed to the Board of Directors of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.